A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-25. Anything still debated is marked as such rather than presented as settled.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
==== MeSH D12.776.503.280.249 – collectins ==== MeSH D12.776.503.280.249.500 – mannose-binding lectin MeSH D12.776.503.280.249.600 – pulmonary surfactant-associated protein a MeSH D12.776.503.280.249.625 – pulmonary surfactant-associated protein d
=== Enhancing creativity === In the 1950s and 1960s, some psychiatrists, such as Oscar Janiger, explored the potential effect of LSD on creativity. Experimental studies attempted to measure the effect of LSD on creative activity and aesthetic appreciation. In 1966, James Fadiman conducted a study with the central question "How can psychedelics be used to facilitate problem solving?" This study attempted to solve 44 different problems and had 40 satisfactory solutions when the FDA banned all research into psychedelics. LSD was a key component of this study.
=== Bioanalytical methods === Bioanalytical methods are necessary to construct a concentration-time profile. Chemical techniques are employed to measure the concentration of drugs in biological matrix, most often plasma. Proper bioanalytical methods should be selective and sensitive. For example, microscale thermophoresis can be used to quantify how the biological matrix/liquid affects the affinity of a drug to its target.
== Annual themes == 2019 - Diversity; diversity of applications, people, careers, locations, technology, science, engineered solutions, and innovation. 2020 - The Cold Chain; role of the Cold chain sector in food safety and security, and human health. 2021 - Careers; aimed at students and young professionals. 2022 - Cooling Matters; raise awareness of the benefits and impacts of cooling, and technology solutions for sustainability. 2023 - Next Generation Cooling; highlighting innovative technologies that improve energy efficiency and promote sustainable practices going into the future. 2024 - Temperature Matters; highlighting the significance of temperature control in daily life.
Salt (sodium chloride), dissolved in water, is used in the canning process, which helps prevent spoilage and can improve sensory characteristics. As a result, canned food can be a major source of dietary salt. Too much salt increases the risk of health problems, including high blood pressure. Therefore, health authorities have recommended limitations of dietary sodium. Many canned products are available in low-salt and no-salt alternatives. Rinsing thoroughly after opening may reduce the amount of salt in canned vegetables, since much of the salt content is thought to be in the liquid, rather than the food itself.
Sources: en.wikipedia.org
The Japanese Black (黒毛和種, kuroge washu), which constitutes over 97% of beef cattle in Japan; regional strains within the breed include the Tottori, Tajima, Shimane and Okayama. The Japanese Brown or Japanese Red (褐毛和種, akage washu or akaushi), the other main breed, representing about 5% of all beef cattle; reared in southern Japan, in Kōchi Prefecture on Shikoku island, and in Kumamoto Prefecture on Kyushu island. The Japanese Polled (無角和種, mukaku washu), found principally in Yamaguchi Prefecture The Japanese Shorthorn (日本短角和種, nihon tankaku washu), reared in northern Japan, mainly in Iwate Prefecture; it constitutes less than one percent of all wagyu cattle.
==== Autoimmune polyendocrine syndrome ==== Autoimmune polyendocrine syndrome type 1 is a rare genetic autoimmune syndrome that results from a genetic defect of the thymus tissue. Specifically, the disease results from defects in the autoimmune regulator (AIRE) gene, which stimulates expression of self-antigens in the epithelial cells within the medulla of the thymus. Because of defects in this condition, self-antigens are not expressed, resulting in T cells that are not conditioned to tolerate body tissues and may treat them as foreign, stimulating an immune response and causing autoimmunity. People with APECED develop an autoimmune disease that affects multiple endocrine tissues, with the commonly affected organs being hypothyroidism of the thyroid gland, Addison's disease of the adrenal glands, and candida infection of body surfaces including the inner lining of the mouth and of the nails due to dysfunction of TH17 cells, and symptoms often beginning in childhood. Many other autoimmune diseases may also occur. Treatment is directed at the affected organs.
The lethal yellow (Ay) mutation is due to an upstream deletion at the start site of agouti transcription. This deletion causes the genomic sequence of agouti to be lost, except the promoter and the first non-encoding exon of Raly, a ubiquitously expressed gene in mammals. The coding exons of agouti are placed under the control of the Raly promoter, initiating ubiquitous expression of agouti, increasing production of pheomelanin over eumelanin and resulting in the development of a yellow phenotype. The viable yellow (Avy) mutation is due to a change in the mRNA length of agouti, as the expressed gene becomes longer than the normal gene length of agouti. This is caused by the insertion of a single intracisternal A particle (IAP) retrotransposon upstream to the start site of agouti transcription. In the proximal end of the gene, an unknown promoter then causes agouti to be constitutionally activated, and individuals to present with phenotypes consistent with the lethal yellow mutation. Although the mechanism for the activation of the promoter controlling the viable yellow mutation is unknown, the strength of coat color has been correlated with the degree of gene methylation, which is determined by maternal diet and environmental exposure. As agouti itself inhibits melanocortin receptors responsible for eumelanin production, the yellow phenotype is exacerbated in both lethal yellow and viable yellow mutations as agouti gene expression is increased.
== History of DHIS development == The original District Health Information Software (DHIS) was developed for three health districts in Cape Town as part of the Health Information Systems Programme (HISP), a collaborative research project between the University of Oslo and the University of the Western Cape that began in 1994.
Sources: en.wikipedia.org
A nasal skin defect of less than 15 mm in diameter can be managed with a bilobed flap; the surgeon trims the edges of the wound (defect) to match its dimensions (length, width, depth) to the natural curve at the border of the nasal tip. If the wound is eccentric, the skin-flap is positioned so that the lateral base of the graft occupies the largest portion of the wound's surface. If the nasal-tip wound is greater than 15 mm in diameter, the surgeon enlarges it to comprehend the entire aesthetic subunit affected by the defect, and the reconstruction of the nasal subunit done with a forehead flap. If the nasal-tip defect also involves the nasal dorsum, a forehead flap is indicated for reconstructing the entire nasal-tip and dorsum. If an alar cartilage is missing, either partially or entirely, it is reconstructed with cartilage grafts. The defect of an alar dome, which retains adequate anatomic support-tripod configuration, can be corrected with an onlay graft harvested either from the nasal septum or from the conchal cartilage of an ear. The surgeon forms the cartilage graft into the shape of a shield—its widest margins become the replacement alar domes. Typically, the shield cartilage graft is stacked in two layers, in order to transmit the desired light reflex characteristic of the nasal tip. Defects of the lateral crura can be corrected with a flat strut of formed cartilage, but, if the support of the medial crura is absent, then a columella strut must be inserted, and attached at the level of the anterior nasal spine.
The enzyme uses the cofactor, reduced nicotinamide adenine dinucleotide phosphate (NADPH). This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 3-oxo-5alpha-steroid:NADP+ Delta4-oxidoreductase. Other names in common use include testosterone Delta4-5alpha-reductase, steroid 5alpha-reductase, 3-oxosteroid Delta4-dehydrogenase, 5alpha-reductase, steroid 5alpha-hydrogenase, 3-oxosteroid 5alpha-reductase, testosterone Delta4-hydrogenase, 4-ene-3-oxosteroid 5alpha-reductase, reduced nicotinamide adenine dinucleotide, phosphate:Delta4-3-ketosteroid 5alpha-oxidoreductase, 4-ene-5alpha-reductase, Delta4-3-ketosteroid 5alpha-oxidoreductase, cholest-4-en-3-one 5alpha-reductase, and testosterone 5alpha-reductase.
The Laténium is an archeology museum located in Laténa, Switzerland. Its name refers to the famous nearby site of La Tène which gave its name to the Second European Iron age. The Laténium is composed of a 2,500 m2 (27,000 ft2) park and a museum building which also harbours the archaeological section of the Heritage Offices of the State of Neuchâtel, as well as the chair of prehistory of the University of Neuchâtel. The museum and its park are built on what used to be three archaeological sites that were excavated during the construction of the A5 motorway. Theses sites date from the Upper Paleolithic, Bronze Age and Neolithic. The park features dolmens and glacial erratics, reconstitutions of prehistoric and antique devices (a La Tène house, a Gallo-Roman ship and a Celtic bridge, notably), and modern works of art. The museum displays the Bevaix boat, a 20 m (66 ft) Gallo-Roman ship found in Bevaix. Items from periods comprised between the Paleolithic to the Middle Ages are on display, including the remains of a Magdalenian hunting camp.
A variety of plants have provided indigo throughout history, but most natural indigo was obtained from those in the genus Indigofera, which are native to the tropics, notably the Indian Subcontinent. The primary commercial indigo species in Asia was true indigo (Indigofera tinctoria, also known as I. sumatrana). A common alternative used in the relatively colder subtropical locations such as Japan's Ryukyu Islands and Taiwan is Strobilanthes cusia. Until the introduction of Indigofera species from the south, Persicaria tinctoria (dyer's knotweed) was the most important blue dyestuff in East Asia; however, the crop produced less dyestuff than the average crop of indigo, and was quickly surpassed in favour of the more economical Indigofera tinctoria plant. In Central and South America, the species grown is Indigofera suffruticosa, also known as anil, and in India, an important species was Indigofera arrecta, Natal indigo. In Europe, Isatis tinctoria, commonly known as woad, was used for dyeing fabrics blue, containing the same dyeing compounds as indigo, also referred to as indigo. Several plants contain indigo, which, when exposed to an oxidizing source such as atmospheric oxygen, reacts to produce indigo dye; however, the relatively low concentrations of indigo in these plants make them difficult to work with, with the color more easily tainted by other dye substances also present in these plants, typically leading to a greenish tinge.
Wenger led training sessions, but delegated responsibility to his coaching staff, who predominantly work with the players. He split the squad into groups, observing and supervising the drills. A typical training session under Wenger lasted 90 minutes, which was timed and staged precisely, and included co-ordination techniques, positional play and small-sided games. Wenger spent the day before a match focusing on the mental and tactical approach of his squad and varied his training style. Wenger regarded a well-balanced diet as an essential part of a player's preparation. He was influenced by his time in Japan, where "the whole way of life there is linked to health. Their diet is basically boiled vegetables, fish and rice. No fat, no sugar. You notice when you live there that there are no fat people". At Arsenal, Wenger brought in dieticians to explain the benefits of a healthy lifestyle, and acquired the help of Philippe Boixel, an osteopath for the France national team, to realign the players' bodies each month. Plyometrics, exercises designed to strengthen the muscles, were introduced and Wenger routinely made players stretch before and after matches. Until 2004, he encouraged his players to take Creatine for increased stamina, later stopping when he noticed side-effects. The innovations had a desirable effect on the team as it prolonged the careers of his defence, and made Arsenal stronger in the second half of seasons. Though Wenger's methods were common in Italian football, they had been unsuccessfully trialled in England until his arrival.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.